Protocol to identify E3 ligases amenable to biodegraders using a cell-based screening

Here, we provide a protocol for the identification of E3 ubiquitin ligases that are functional when implemented as biodegraders using a cell-based screening assay. We describe steps for establishing a stable cell line expressing a GFP-tagged protein of interest (POI), preparing a sub-library of E3 ligases to screen, and performing the cell-based screening. This protocol can be broadly applied to identify any functional E3 ligase in a biodegrader setting. For complete details on the use and execution of this protocol, please refer to Cornebois et al.<sup>1</sup>.

Authors

Institutions

Publication Details

Journal
STAR Protocols
Published
2024-10-24
DOI
https://doi.org/10.1016/j.xpro.2024.103413
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protocol to identify E3 ligases amenable to biodegraders using a cell-based screening

Klervi Desrumeaux, Nicolas Béry, Marie Sorbara, Pierre Cordelier et al.
STAR Protocols
Protein Degradation and Inhibitors
article

Protocol to identify E3 ligases amenable to biodegraders using a cell-based screening

Klervi Desrumeaux, Nicolas Béry, Marie Sorbara, Pierre Cordelier, Anaïs Cornebois, Margot Cristol
article en

Abstract

Here, we provide a protocol for the identification of E3 ubiquitin ligases that are functional when implemented as biodegraders using a cell-based screening assay. We describe steps for establishing a stable cell line expressing a GFP-tagged protein of interest (POI), preparing a sub-library of E3 ligases to screen, and performing the cell-based screening. This protocol can be broadly applied to identify any functional E3 ligase in a biodegrader setting. For complete details on the use and execution of this protocol, please refer to Cornebois et al.<sup>1</sup>.

STAR ProtocolsVol. 5(4)
Centre National de la Recherche Scientifique (FR), Université Toulouse III - Paul Sabatier (FR), Inserm (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Sanofi (France) (FR), Centre de Recherches en Cancérologie de Toulouse (FR)
Sanofi, Institut National de la Santé et de la Recherche Médicale, Association Nationale de la Recherche et de la Technologie, Ligue Contre le Cancer, Fondation de France, Inserm Transfert
Zero hunger
Openalex Percentile: Top 83%
Protein Degradation and Inhibitors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.